Rania A Gad
Overview
Explore the profile of Rania A Gad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akila A, Gad R, El-Din Ewees M, Abdul-Hamid M, Abdel-Reheim E
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Sep;
PMID: 39235475
Gentamicin (Genta)-induced nephrotoxicity poses a significant clinical challenge due to its detrimental effects on kidney function. Clopidogrel (Clop), an antiplatelet drug known for its ability to prevent blood clots by...
2.
Elhabal S, Abdelaal N, Saeed Al-Zuhairy S, Elrefai M, Hamdan A, Khalifa M, et al.
Int J Nanomedicine
. 2024 Apr;
19:3045-3070.
PMID: 38559447
Background: Diabetes Mellitus is a multisystem chronic pandemic, wound inflammation, and healing are still major issues for diabetic patients who may suffer from ulcers, gangrene, and other wounds from uncontrolled...
3.
Elhabal S, Abdelaal N, Al-Zuhairy S, Elrefai M, Khalifa M, Khasawneh M, et al.
Int J Nanomedicine
. 2024 Feb;
19:1163-1187.
PMID: 38344440
Purpose: Improving the treatment of psoriasis is a serious challenge today. Psoriasis is an immune-mediated skin condition affecting 125 million people worldwide. It is commonly treated with cyclosporine-A (CsA) and...
4.
Hassanein E, Abdel-Reheim M, Althagafy H, Hemeda M, Gad R, Abdel-Sattar A
Naunyn Schmiedebergs Arch Pharmacol
. 2023 Nov;
397(6):3985-3994.
PMID: 37994949
Indomethacin (INDO) is an NSAID with remarkable efficacy and widespread utilization for alleviating pain. Nevertheless, renal function impairment is an adverse reaction linked to INDO usage. Nifuroxazide (NFX), an oral...
5.
El-Rahman A, El-Shafei S, Shehab G, Mansour L, Abuelsaad A, Gad R
Life (Basel)
. 2023 Sep;
13(9).
PMID: 37763219
Background: Epilepsy is a serious chronic neurological disorder, which is accompanied by recurrent seizures. Repeated seizures cause physical injuries and neuronal dysfunction and may be a risk of cancer and...
6.
Elhabal S, El-Nabarawi M, Abdelaal N, Elrefai M, Ghaffar S, Khalifa M, et al.
Drug Deliv
. 2023 Aug;
30(1):2241665.
PMID: 37537858
Canagliflozin (CFZ) is a sodium-glucose cotransporter-2 inhibitor (SGLT2) that lowers albuminuria in type-2 diabetic patients, cardiovascular, kidney, and liver disease. CFZ is classified as class IV in the Biopharmaceutical Classification...
7.
Elhabal S, Ghaffar S, Hager R, Elzohairy N, Khalifa M, Mohie P, et al.
Int J Pharm X
. 2023 Mar;
5:100174.
PMID: 36908304
The most prevalent conditions among ocular surgery and COVID-19 patients are fungal eye infections, which may cause inflammation and dry eye, and may cause ocular morbidity. Amphotericin-B eye drops are...
8.
Gad R, Abdel-Reheim E, Shehab G, Hafez H, Abuelsaad A
Comb Chem High Throughput Screen
. 2020 Aug;
24(6):767-780.
PMID: 32772909
Background: Nonalcoholic steatohepatitis (NASH) is associated with activation of liver fibrogenesis and predisposes to cirrhosis and associated morbi-mortality. A high fat high cholesterol diet (HFD) was provided to female albino...